A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares.

Autor: Dulai PS; University of California San Diego, La Jolla, CA, USA., Raffals LE; Mayo Clinic, Rochester, MN, USA., Hudesman D; NYU Langone Health, New York, NY, USA., Chiorean M; Virginia Mason, Seattle, WA, USA., Cross R; University of Maryland, Baltimore, MD, USA., Ahmed T; University of Texas Southwestern Medical Center, Dallas, TX, USA., Winter M; Dartmouth Hitchcock Medical Center, Lebanon, NH, USA., Chang S; NYU Langone Health, New York, NY, USA., Fudman D; University of Texas Southwestern Medical Center, Dallas, TX, USA., Sadler C; University of California San Diego, La Jolla, CA, USA., Chiu EL; NYU Langone Health, New York, NY, USA., Ross FL; NYU Langone Health, New York, NY, USA., Toups G; Mayo Clinic, Rochester, MN, USA., Murad MH; Mayo Clinic, Rochester, MN, USA., Sethuraman K; University of Maryland, Baltimore, MD, USA., Holm JR; Virginia Mason, Seattle, WA, USA., Guilliod R; University of Texas Southwestern Medical Center, Dallas, TX, USA., Levine B; University of Texas Southwestern Medical Center, Dallas, TX, USA., Buckey JC Jr; Dartmouth Hitchcock Medical Center, Lebanon, NH, USA., Siegel CA; Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Sep; Vol. 52 (6), pp. 955-963. Date of Electronic Publication: 2020 Aug 03.